The neuroprotective potentiality of flavonoids on Alzheimer's disease

A Calderaro, GT Patanè, E Tellone, D Barreca… - International journal of …, 2022 - mdpi.com
Alzheimer's disease (AD), due to its spread, has become a global health priority, and is
characterized by senile dementia and progressive disability. The main cause of AD and …

Molecular dynamics-driven drug discovery: leaping forward with confidence

A Ganesan, ML Coote, K Barakat - Drug discovery today, 2017 - Elsevier
Highlights•Currently, developing a market-approved drug costs a staggering $2.6 billion.•In
silico methods have become an important strategy for narrowing down on promising lead …

Molecular insight into the binding property and mechanism of sulfamethoxazole to extracellular proteins of anammox sludge

GF Li, WJ Ma, ZQ Ren, Y Wang, JP Li… - Environmental …, 2021 - ACS Publications
Antibiotics are widely found in nitrogen-containing wastewater, which may affect the
operation stability of anaerobic ammonium oxidation (anammox)-based biological treatment …

An overview of 1, 2, 3-triazole-containing hybrids and their potential anticholinesterase activities

SA Khan, MJ Akhtar, U Gogoi, DU Meenakshi, A Das - Pharmaceuticals, 2023 - mdpi.com
Acetylcholine (ACh) neurotransmitter of the cholinergic system in the brain is involved in
learning, memory, stress responses, and cognitive functioning. It is hydrolyzed into choline …

Explore the effect of the structure-activity relationship and dose-effect relationship on the antioxidant activity of licorice flavonoids

Y Hu, P Liang, Z Wang, CP Jiang, Q Zeng… - Journal of Molecular …, 2023 - Elsevier
Licorice flavonoids (LCF) are one of the homologous substances of medicine and food,
which have good antioxidant activity. However, the molecular mechanism affecting its …

Crystal structure of human acetylcholinesterase in complex with tacrine: Implications for drug discovery

KV Dileep, K Ihara, C Mishima-Tsumagari… - International Journal of …, 2022 - Elsevier
Alzheimer's disease (AD) is one of the most common, progressive neurodegenerative
disorders affecting the aged populations. Though various disease pathologies have been …

Spike protein recognizer receptor ACE2 targeted identification of potential natural antiviral drug candidates against SARS-CoV-2

S Pokhrel, TA Bouback, A Samad, SM Nur… - International Journal of …, 2021 - Elsevier
Abstract Angiotensin-converting enzyme 2 (ACE2), also known as peptidyl-dipeptidase A,
belongs to the dipeptidyl carboxydipeptidases family has emerged as a potential antiviral …

Synergistic Effects of Curcumin and Piperine as Potent Acetylcholine and Amyloidogenic Inhibitors With Significant Neuroprotective Activity in SH-SY5Y Cells via Computational …

AS Abdul Manap, AC Wei Tan, WH Leong… - Frontiers in aging …, 2019 - frontiersin.org
Hallmarks of Alzheimer's disease (AD) pathology include acetylcholine (ACh) deficiency and
plaque deposition. Emerging studies suggest that acetylcholinesterase (AChE) may interact …

Design, synthesis, and pharmacological evaluation of embelin–aryl/alkyl amine hybrids as orally bioavailable blood–brain barrier permeable multitargeted agents with …

VK Nuthakki, S Choudhary, CN Reddy… - ACS chemical …, 2023 - ACS Publications
The complex and multifaceted nature of Alzheimer's disease has brought about a pressing
demand to develop ligands targeting multiple pathways to combat its outrageous …

Phenoxyethyl piperidine/morpholine derivatives as PAS and CAS inhibitors of cholinesterases: insights for future drug design

Y Pourshojaei, A Abiri, K Eskandari, Z Haghighijoo… - Scientific reports, 2019 - nature.com
Acetylcholinesterase (AChE) catalyzes the conversion of Aβ peptide to its aggregated form
and the peripheral anionic site (PAS) of AChE is mainly involved in this phenomenon. Also …